We have placed cookies on your computer to help make this website better. We use a Matomo Analytics script which sets performance cookies. More details and information can be found in our cookie policy. Please refer to the privacy statement to adjust your settings for the website analytics tracking by Matomo (e.g. deny use/opt-out).

The Grünenthal Group is an entrepreneurial, science-based pharmaceutical company specialized in pain, gout and inflammation. We are a fully integrated research & development company with a long track record of bringing innovative pain treatments and state-of-the-art technologies to patients.

... About us

We are an independent, family-owned company with headquarters in Aachen, Germany. We are present in 32 countries with affiliates in Europe, Latin America and the USA. Our products are sold in more than 155 countries and we employ around 5,200 employees worldwide.

... Company Overview

Although firmly rooted in Germany, today we are very much a growing global Business.

... History

A mix of strong entrepreneurial spirit, close collaboration and outstanding performance define our approach to leadership alongside a commitment to diversity and inclusivity.

... Leadership

Beyond our overarching purpose – to improve the health of people around the globe – we want to create shared value through sustainability for our company and society as a whole.

... Responsibility

In view of our vision of a world free of pain, Grünenthal strives to provide effective medication to patients worldwide. Therefore, we continuously grow and expand our market presence and product portfolio, and we collaborate with commercial partners and multiple stakeholders from the pain management field and beyond.

... Global presence & sites

Patients’ needs are at the heart of everything we do; using our passion for science, we develop long-lasting solutions that directly address these needs.

... Products

We are dedicated to creating a better future for our patients, so getting involved with diverse initiatives that support this goal is vital.

... Initiatives

Innovation is at the heart of everything that we do. It’s the driving force behind new ideas and future therapies.

... Research & Development

For us, innovation goes beyond drug development. Our innovation is built on expert knowledge of disease-pathophysiology’s, understanding of the patient, the use of big data and state-of-the-art technologies such as devices that result in innovative solutions for the patients need.

... Strategy

Our R&D pipeline is a source of great excitement – we currently have several new drug candidates and technologies in different phases of development.

... Pipeline

Our key innovation area is pain.

... Focus area

Collaboration with the scientific community is central to our R&D strategy. Let’s work together – collaborate with us!

... Collaborate with us

Global leaders in pain research

Re-defining pain through patient-inspired R&D

Pain is a huge burden on society, impacting not only patients but their families, friends and colleagues. There has been limited success in discovering new pain treatments. Many conditions have no standard of care and in cases where they do exist, they have limited efficacy. We want to change this.

We want to re-define the field of pain, creating specialised treatments through patient-inspired R&D.
We aim to:

Better understand the DISEASE state to identify new TARGETs
Develop treatments with both symptomatic and disease-modifying potential
Improve our understanding of the link between inflammation and pain
Target significant unmet needs within niche disease areas
Broaden our research reach through partnerships and collaborations
Investigate small molecule approaches.

We will achieve our goals by bringing together patient experience, payors’ needs and innovation networks.

Pain Spectrum

Explore the PainSpectrum with our interactive Body map of almost 100 different pain conditions, developed in collaboration with expert academic centres.

... Discover more

A different approach

We see pain as a disease, not a symptom

We understand pain is not just a symptom but also an entire condition in itself that requires specialised treatment. We know that pain is different for everyone and the experience and symptoms don’t just depend on the type of condition, but also the individual patient. By understanding how and why pain is generated in a variety of conditions; we are driving development into innovative pain solutions that will have a truly meaningful impact on patient lives.

Patient perspective

Patients are central in the journey towards developing effective pain solutions. Through our work with patient organisations and direct interaction with patients, we have been able to create tangible improved outcomes for patients.

Medical expert perspective

Expert knowledge from medical professionals and researchers is the foundation for our research.

Basic science perspective

Through patient and control tissues, we are starting to identify which genes, RNAs, proteins or metabolites are involved in different disease characteristics.